Dr. Jack Cush reviews the terms in rheumatology that should no longer be used in the field of rheumatology. This lecture is part of the RheumNow Live 2024 meeting, being held January 27-28, 2024 in Dallas, TX (and virtually).
Treat to Target Outcomes in Early AxSpA
Does Telemonitoring in SpA Work?
PsA Treatment: is Earlier Better?
JAK Inhibitors for New Indications
Transition from Psoriasis to PsA: Can we Prevent It?
EULAR 2024 Daily Recap - Days 1 & 2
Mechanistic Promise in RA Doesn’t Always Mean Actual Gain
The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Voclosporin and Steroids in Lupus Nephritis
3 Big Lupus Themes from EULAR 2024
Does B Cell Depletion Matter?
Do MRI changes at the Spine and SI Joints in Treatment of AxSpA Matter?
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Is Cannabis Safe? (6.7.2024)
ACR’s Run at Goliath (PCPs) (5.31.2024)
The Window of Opportunity (5.24.2024)
Don't You Know Who I am (5.17.2024)
My Cancelled Lecture (5.11.2024)
Create your
podcast in
minutes
It is Free
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Peter Attia Drive
The Doctor’s Farmacy with Mark Hyman, M.D.